Thinking Of Selling ClearPoint Neuro Inc (NASDAQ: CLPT) Stock? First, You Need To See This

RLX

ClearPoint Neuro Inc (NASDAQ:CLPT) price on Thursday, February 27, fall -17.51% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $14.20.

A look at the stock’s price movement, the close in the last trading session was $17.22. Turning to its 52-week performance, $19.22 and $5.11 were the 52-week high and 52-week low respectively. Overall, CLPT moved -20.82% over the past month.

ClearPoint Neuro Inc’s market cap currently stands at around $391.84 million, with investors looking forward to this quarter’s earnings report slated for in March.

Analysts have a consensus estimate of 8.24M for the company’s revenue for the quarter, with a low and high estimate of 7.9M and 8.72M respectively. The average forecast suggests up to a 7.86% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 38.25M, representing a 21.84% jump on that reported in the last financial year.

Turning to the stock’s technical picture we see that short term indicators suggest on average that CLPT is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.

CLPT’s current price about -19.32% and -14.53% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.18, while 7-day volatility ratio is 8.19% and 6.16% in the 30-day chart. Further, ClearPoint Neuro Inc (CLPT) has a beta value of 1.04, and an average true range (ATR) of 1.17. Analysts have given the company’s stock an average 52-week price target of $30, forecast between a low of $30 and high of $30. Looking at the price targets, the low is -111.27% off current price level while to achieve the yearly target high, price needs to move -111.27%. Nonetheless, investors will most likely welcome a -111.27% jump to $30 which is the analysts’ median price.

If we refocus on ClearPoint Neuro Inc (NASDAQ:CLPT), historical trading data shows that trading volumes averaged 217.64K over the past 3 months. The company’s latest data on shares outstanding shows there are 27.62 million shares.

The 13.38% of ClearPoint Neuro Inc’s shares are in the hands of company insiders while institutional holders own 27.99% of the company’s shares. Current price change has pushed the stock -7.64% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CLPT stock continues to rise going into the next quarter.

Most Popular